摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(chloromethyl)-6-chloronaphthalene | 60200-38-6

中文名称
——
中文别名
——
英文名称
2-(chloromethyl)-6-chloronaphthalene
英文别名
2-chloro-6-(chloromethyl)naphthalene;2-chloro-6-chloromethylnaphthalene;2-chloromethyl-6-chloronaphthalene;6-Chlor-2-chlormethylnaphtalin
2-(chloromethyl)-6-chloronaphthalene化学式
CAS
60200-38-6
化学式
C11H8Cl2
mdl
——
分子量
211.091
InChiKey
NKNWDMQCOPTACU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    110-111 °C(Solv: ligroine (8032-32-4))
  • 沸点:
    332.4±17.0 °C(Predicted)
  • 密度:
    1.293±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(chloromethyl)-6-chloronaphthalene氢氧化钾sodium hydroxide 、 Acylase Amano 15000 、 sodium ethanolate 、 cobalt(II) chloride 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 (2S)-2-amino-3-(6-chloronaphthalen-2-yl)propanoic acid
    参考文献:
    名称:
    Studies on Neurokinin Antagonists. 4. Synthesis and Structure-Activity Relationships of Novel Dipeptide Substance P Antagonists: N2-[(4R)-4-Hydroxy-1-[(1-methyl-1H-indol-3-yl)carbonyl]-L-prolyl]-N-methyl-N-(phenylmethyl)-3-(2-naphthyl)-L-alaninamide and Its Related Compounds
    摘要:
    As an extension of our studies on discovering a novel substance P (SP) antagonist, we modified the previously reported dipeptide, N-2-[N-2-(1H-indol-3-ylcarbonyl)-L-lysyl]-N-methyl-N-(phenylmethyl)-L-phenylalaninamide (2b). The lysine part in 2b was first optimized to a (2S,4R)hydroxyproline derivative (3h),which is 2-fold more potent than 2b in [H-3]SP binding assay using guinea pig lung membranes. Next we modified the 1H-indol-3-ylcarbonyl part in 3h. Introduction; of a methyl group at the indole nitrogen enhanced the oral activity, while retaining the binding activity. Finally, we modified the phenylalanine part to culminate in the most potent compound 7k (FK888), which is a potent SP antagonist with NK1 selectivity as well as oral activity.
    DOI:
    10.1021/jm00039a022
  • 作为产物:
    参考文献:
    名称:
    使用聚苯乙烯-交联双膦配体的芳基氯化物与烷基锂之间的异质镍催化交叉偶联
    摘要:
    聚苯乙烯交联双膦配体PS-DPPBz用于Ni催化与有机锂的交叉偶联。稳定的前催化剂[NiCl 2(PS-DPPBz)]使芳基氯化物与烷基锂之间的有效偶联反应成为可能。Ni的异质体系显示出良好的可重用性。
    DOI:
    10.1002/adsc.201801713
点击查看最新优质反应信息

文献信息

  • [EN] 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES AND THEIR USE AS 11-BETAHSD1 INHIBITORS<br/>[FR] DERIVES DE PIPERIDINE 1,4 DISUBSTITUEE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE 11-BETAHSD1
    申请人:ASTRAZENECA AB
    公开号:WO2004033427A1
    公开(公告)日:2004-04-22
    The use of a compound of formula (I) in the manufacture of a medicament for use in the inhibition of 11βHSD1 is described.
    使用式(I)的化合物制造用于抑制11βHSD1的药物。
  • Sulfone derivatives, process for their production and use thereof
    申请人:——
    公开号:US20030187023A1
    公开(公告)日:2003-10-02
    A compound represented by the formula: 1 wherein R is a cyclic hydrocarbon group, or the like; W is a bond, or the like; X is a divalent hydrocarbon group, or the like; Y and Z are each independently —N(R 6 )— or the like; ring A is a nitrogen-containing heterocyclic ring, or the like; R5 and R6 are independently hydrogen atom, a hydrocarbon group, or the like; Z′ is imidoyl group, or the like; a is 0, 1 or 2; and b is 0 or 1, or a salt thereof.
    一个由以下式表示的化合物: 其中R是一个环烃基团,或类似物;W是一个键,或类似物;X是一个二价碳氢基团,或类似物;Y和Z分别独立地为—N(R6)—或类似物;环A是一个含氮杂环环,或类似物;R5和R6独立地为氢原子、一个碳氢基团,或类似物;Z′是亚胺基团,或类似物;a为0、1或2;b为0或1,或其盐。
  • 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
    申请人:Barton John Peter
    公开号:US20050256159A1
    公开(公告)日:2005-11-17
    A method for inhibiting 11βHSD1 by administering a compound of formula (I) is described, wherein A, X, Y, R 1 , R 12 , n, q, and m are as described in the specification. Novel compounds and methods employing them are also described and claimed.
    本发明涉及一种通过给予式(I)化合物来抑制11βHSD1的方法,其中A、X、Y、R1、R12、n、q和m如规范中所述。本发明还描述和声明了新的化合物和使用它们的方法。
  • Substituted aryloxy-3,3,3-trifluoro-2-propionic acids, esters and salts
    申请人:Imperial Chemical Industries Limited
    公开号:US04055595A1
    公开(公告)日:1977-10-25
    Derivatives of 2-hydroxy-3,3,3-trifluoro-2-(alkyl or trifluoromethyl)propionic acid bearing a phenyl or naphthyl group linked to the 2-hydroxy group either directly or via an intermediate methylene group. The compounds reduce the concentrations of cholesterol, total esterified fatty acids or fibrinogen in the blood plasma of test animals and some compounds show anti-arthritic properties.
    2-羟基-3,3,3-三氟-2-(烷基或三氟甲基)丙酸的衍生物,带有连接到2-羟基的苯基或萘基,可以直接连接或通过中间的亚甲基连接。这些化合物可以降低实验动物血浆中的胆固醇、总酯化脂肪酸或纤维蛋白原浓度,其中一些化合物还具有抗关节炎的特性。
  • Fluorinated compounds as therapeutics
    申请人:Imperial Chemical Industries Limited
    公开号:US04107329A1
    公开(公告)日:1978-08-15
    Derivatives of 2-hydroxy-3,3,3-trifluoro-2-(alkyl or trifluoromethyl)propionic acid bearing a phenyl or naphthyl group linked to the 2-hydroxy group either directly or via an intermediate methylene group. The compounds reduce the concentrations of cholesterol, total esterified fatty acids or fibrinogen in the blood plasma of test animals and some compounds show anti-arthritic properties.
    2-羟基-3,3,3-三氟-2-(烷基或三氟甲基)丙酸的衍生物,其中带有苯基或萘基,连接到2-羟基基团,可以直接连接或通过中间的亚甲基基团连接。这些化合物可以降低试验动物血浆中的胆固醇、总酯化脂肪酸或纤维蛋白原浓度,其中一些化合物还具有抗关节炎的特性。
查看更多